Approval · Notice of Compliance 2301 · 2001
TEQUIN: Notice of Compliance 2301
Issued January 9, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2301
- Date
- January 9, 2001
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antibacterial agent
Products in this notice
Medicinal ingredients
- GATIFLOXACIN 200 MG per TAB
- GATIFLOXACIN 400 MG per TAB
- GATIFLOXACIN 10 MG per ML
- GATIFLOXACIN 2 MG per ML